Emmaus Life Sciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-2.2M | $-2.2M | — | $241.7K |
| FY2016 | $-3.0M | $-3.0M | $4.0K | $834.7K |
| FY2017 | $-4.8M | $-4.9M | $127.9K | $2.1M |
| FY2018 | $-9.0M | $-5.7M | $55.2K | $1.6M |
| FY2019 | $-4.5M | $-4.6M | $60.0K | — |
| FY2020 | $-2.5M | $-2.5M | $15.0K | $739.0K |
| FY2021 | $-1.3M | $-1.3M | $73.0K | $553.0K |
| FY2022 | $-5.1M | $-5.1M | $26.0K | $16.0K |
| FY2023 | $-1.5M | $-1.5M | $17.0K | $1.3M |
| FY2024 | $-2.3M | $-2.3M | $12.0K | $256.0K |